UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014358
Receipt number R000016641
Scientific Title Efficacy and Safety of pleurodesis with 50% glucose solution: an open-label, uncontrolled study
Date of disclosure of the study information 2014/06/23
Last modified on 2017/04/17 08:59:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy and Safety of pleurodesis with 50% glucose solution: an open-label, uncontrolled study

Acronym

Efficacy and Safety of pleurodesis with 50% glucose solution: an open-label, uncontrolled study

Scientific Title

Efficacy and Safety of pleurodesis with 50% glucose solution: an open-label, uncontrolled study

Scientific Title:Acronym

Efficacy and Safety of pleurodesis with 50% glucose solution: an open-label, uncontrolled study

Region

Japan


Condition

Condition

Refractory pneumothorax or malignant pleural effusion

Classification by specialty

Pneumology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and safety of pleurodesis with 50% glucose solution for patients with refractory pneumothorax or malignant pleural effusion.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Effectiveness of pleurodesis with 50% glucose solution

Key secondary outcomes

1.Dyspnea and chest pain
2.Safety


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

pleurodesis by intrapleural administration of 200ml of 50% glucose solution

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Patients with pneumothorax or malignant pleural effusion
2.Written informed consent

Key exclusion criteria

1.uncontrollable diabetes
2.unstable angina or myocardial infarction within one month
3.pregnancy
4.inappropriate patients for this study judged by the physicians

Target sample size

46


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masamitsu Nakazato

Organization

University of Miyazaki

Division name

Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine

Zip code


Address

Kihara 5200, Kiyotake, Miyazaki 889-1692, Japan

TEL

0985-85-2965

Email

nakazato@med.miyazaki-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yasuji Arimura

Organization

University of Miyazaki

Division name

Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine

Zip code


Address

Kihara 5200, Kiyotake, Miyazaki 889-1692, Japan

TEL

0985-85-2965

Homepage URL


Email

yasuji_arimura@med.miyazaki-u.ac.jp


Sponsor or person

Institute

University of Miyazaki

Institute

Department

Personal name



Funding Source

Organization

University of Miyazaki

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 06 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2014 Year 05 Month 27 Day

Date of IRB


Anticipated trial start date

2014 Year 06 Month 24 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 06 Month 23 Day

Last modified on

2017 Year 04 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016641


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name